Implementation of newborn screening programs in Africa: a scoping review
Stanford Chigaro, Rabelani Kaela, Takudzwa Marembo, Solomon Mukwenha, Maria Mvere
Corresponding author: Stanford Chigaro, College of Public Health, Texila American University, Lusaka, Zambia 
Received: 06 Dec 2025 - Accepted: 25 Sep 2026 - Published: 16 Nov 2026
Domain: Public health
Keywords: Newborn screening, child health, Africa
Funding: This work received no specific grant from any funding agency in the public, commercial, or non-profit sectors.
©Stanford Chigaro et al. Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Cite this article: Stanford Chigaro et al. Implementation of newborn screening programs in Africa: a scoping review. Pan African Medical Journal. 2026;55:120. [doi: 10.11604/pamj.2026.55.120.50513]
Available online at: https://www.panafrican-med-journal.com//content/article/55/120/full
Implementation of newborn screening programs in Africa: a scoping review
Stanford Chigaro1,&, Rabelani Kaela2,
Takudzwa Marembo3,4,
Solomon Mukwenha1, Maria Mvere5
&Corresponding author
Newborn screening (NBS) enables early detection and management of genetic, metabolic, and endocrine disorders, which reduces preventable morbidity and mortality in infants. NBS is routine in many high-income countries, but its implementation across Africa remains limited and fragmented despite the region's high burden of screenable conditions such as sickle cell disease and congenital hypothyroidism. This scoping review assessed the current status of NBS implementation in Africa, identified commonly screened conditions, and explored barriers and facilitators influencing program adoption and sustainability. Following the Arksey and O'Malley framework and reported according to PRISMA-ScR guidelines, a systematic search of PubMed was conducted for studies published between 2010 and 2024. Eleven studies met the inclusion criteria, representing programs in Zambia, Nigeria, South Africa, Tanzania, Ghana, Kenya, Uganda, Cameroon, Liberia, Angola, and the Democratic Republic of Congo. Thematic analysis revealed that most NBS programs were small-scale, pilot, or hospital-based initiatives, primarily targeting SCD. Major barriers to implementation included limited financial resources, shortage of trained personnel, inadequate laboratory infrastructure, weak governance, and low community awareness. Dependence on external funding and the absence of comprehensive national policies further undermined program sustainability. Facilitating factors included international collaborations, government engagement, and community education, which improved awareness and uptake in pilot regions. The review highlights the urgent need for coordinated continental action to transition from pilot projects to comprehensive, sustainable NBS programs that promote health equity and improve child survival outcomes in Africa.
Newborn screening (NBS) is a crucial public health intervention aimed at the early identification of certain genetic, metabolic, and endocrine disorders in infants [1]. Early detection of conditions such as sickle cell disease (SCD), congenital hypothyroidism, and thalassemia allows for prompt diagnosis and treatment, which can prevent severe complications, irreversible damage, or even death. The potential of NBS to reduce morbidity and mortality has been well-documented, with countries implementing these programs reporting significant improvements in child health outcomes [2-4]. Available data suggest that inborn errors of metabolism occur in approximately 1 in 1,900 live births, while an estimated 300,000 infants are born annually with significant haemoglobinopathies such as SCD [1]. As such, NBS is recognised as an essential component of child health services in many parts of the world, particularly in high-income countries where these programs are now routine and universal.
In Africa, the implementation of NBS remains limited despite the disproportionately high burden of screenable conditions [1]. For instance, SCD, which affects millions of people in sub-Saharan Africa (SSA), leads to significant morbidity and early mortality, with 50-90% of affected infants dying before the age of five if undiagnosed [5]. Early diagnosis through NBS offers the opportunity to provide lifesaving interventions, such as early prophylactic antibiotics and parental education, but few countries have implemented systematic screening programs for SCD or other conditions [6].
Despite significant challenges in some African countries, there are growing efforts to implement and expand NBS programs. Countries such as Ghana and Nigeria have launched pilot NBS programs, primarily focused on screening for SCD [7]. South Africa has implemented limited NBS for congenital hypothyroidism and other metabolic disorders, though coverage is not universal [8]. In some cases, international partnerships with global health organisations, research institutions, and donor agencies have been pivotal in supporting the introduction of NBS programs on the continent [9].
The World Health Organisation (WHO) has emphasised the importance of integrating NBS into national health systems as a means of improving child survival rates and enhancing health outcomes for children born with congenital or metabolic conditions [10]. However, the progress made in high-income countries has yet to be replicated in most parts of Africa [1]. The lack of data and systematic reviews on the state of NBS across the continent has limited the ability of policymakers and stakeholders to assess current practices and develop strategies for scaling up programs. Understanding the current landscape of NBS in Africa is therefore essential to identifying the key challenges and opportunities for implementation and scale-up.
This scoping review aims to provide a comprehensive assessment of the implementation of NBS programs across Africa. The study seeks to map the progress made by various countries in developing and scaling NBS programs, identify common barriers and facilitators to implementation, and highlight gaps in knowledge that need to be addressed to improve child health outcomes. Specifically, the review addresses the following key questions: What is the current status of NBS program implementation across African countries? Which conditions are commonly screened, and what screening methodologies are employed? What are the barriers and facilitators to implementing NBS in African settings?
By synthesising available evidence, this review seeks to contribute to the body of knowledge on NBS in Africa, providing a foundation for policymakers, health professionals, and researchers to advocate for and develop more robust NBS programs. The lessons learned from this review will help guide future policy development, international collaborations, and health system strengthening efforts, ultimately contributing to a significant reduction in preventable infant mortality and morbidity in Africa.
Study design: a scoping review approach was employed as it was deemed the most appropriate to address the research questions. The review process followed the Arksey and O'Malley framework [11], which outlines sequential stages involving the formulation of the research question, identification of pertinent literature, selection of eligible studies, systematic data charting, and the synthesis and presentation of findings. Quality appraisal of the included studies was conducted using the Mixed Methods Appraisal Tool (MMAT) version 2018 [12]. Reporting of the review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) guidelines [13].
Search strategy: this scoping review was conducted by a systematic search on PubMed using the keywords: "newborn screening", "Neonatal screening", "Congenital disorder screening", "Low and middle-income countries", "Africa," and "newborn screening implementation". Boolean terms, "and" and "or", were used to separate the search terms. Only PubMed was searched because it offers comprehensive coverage of biomedical and public health literature, including most journals publishing on NBS. The review included articles published between 2010 and 2024. In addition, the reference lists of studies meeting the inclusion criteria were searched for relevant studies. Data extracted included: country of implementation, screening strategies (targeted or universal), conditions screened, screening techniques used, and health system challenges and facilitators. Screening of the retrieved articles following database search was undertaken in stages. Initially, the principal researcher reviewed the article titles. Subsequently, two co-researchers independently screened the abstracts and full articles in parallel. Discrepancies in reviewers' responses at full article screening stage were resolved through discussion. Kappa statistics was employed to assess the level of agreement between the two co-researchers at each stage.
Inclusion criteria: studies conducted in Africa between January 2010 and December 2024, and published in English. Studies on NBS, including pilot programs.
Exclusion criteria: articles reporting on NBS outside Africa. Articles published before January 2010 and after December 2024.
Charting of data: a standardised data extraction form was used to collect information from included studies on author, publication year, location, study aim, design, population, and type of NBS service.
Collating, summarising and reporting of the results: the review employed thematic content analysis to examine findings from the included articles, with themes extracted using NVIVO version 12.
Quality appraisal of included primary studies: the quality of included articles was assessed using the MMAT version 2018, which evaluates methodological quality across five study categories: qualitative, quantitative randomised, quantitative non-randomised, quantitative descriptive, and mixed methods studies. Two reviewers independently appraised each study against the relevant MMAT criteria, calculating percentage quality scores. Discrepancies were resolved through discussion. Scores of ≤50% were considered low quality, 51–75% as average quality, and 76–100% as high quality.
Screening results: following database search, 443 potentially eligible articles were retrieved. A total of 102 duplicates were removed, leaving the total number of articles eligible for screening at 341. Of the 341 articles, 60 were eligible for inclusion in abstract screening. Following abstract screening, 29 articles were excluded, leaving 31 articles for full-text review. Further, 20 articles were excluded after full articles review, and 11 articles were included in this study. Agreement between the two co-researchers was fair, with the following results: kappa statistic = 0.73. Figure 1 shows a flow diagram of the screening results.
Characteristics of included studies: the characteristics of included studies are shown in Table 1, Table 1.1, Table 1.2, Table 1.3 and Table 1.4. The studies were conducted in Zambia, Nigeria, South Africa, Tanzania, Ghana, Kenya, Uganda, Cameroon, Liberia, Angola and the Democratic Republic of Congo. All included studies reported on implementation of NBS programs and were published between 2010 and 2024. Of the included studies, 7 were cross-sectional, 1 cohort, 2 prospective studies, and 1 pre-post-test. No grey literature was included in this scoping review.
Quality assessment of included primary studies: all 11 included studies underwent quality assessment guided by the MMAT version 2018. One study scored 60%, while 10 scored 100%.
Themes that emerged from the study: the studies across different African regions collectively highlight recurring themes in the implementation of NBS for conditions such as SCD, hearing impairment, and HIV exposure. These themes reflect the broader structural, social, and systemic challenges faced by public health systems in low-resource settings. The studies also call for urgent action to strengthen NBS implementation across the continent.
Poor coverage of NBS programs: only a few African countries have established national NBS programs, but most of these focus on a single condition, typically SCD. For example, Ghana and Nigeria have pilot programs that screen newborns for SCD only [1,5]. South Africa has regional initiatives and pilot projects for screening genetic, metabolic, and endocrine disorders, including congenital hypothyroidism, but lacks a fully implemented national NBS program [14]. Universal NBS is rare across the continent, with most programs being small-scale and geographically limited [5]. Most NBS programs are at the pilot or early implementation stage. The studies consistently indicate that screening for conditions such as SCD and hearing impairment is largely confined to research-led or hospital-based initiatives rather than fully institutionalised national programs [1,5,15-18]. Two studies describe ongoing efforts to establish universal SCD screening across multiple African countries [1,5], while another study emphasises that programs in Tanzania remain localised and dependent on external support [16]. A study conducted in South Africa [19] and another in Nigeria [18] similarly highlighted that NBS is fragmented and lacks systematic integration into national health services.
NBS implementation feasibility and operational challenges: a central theme emerging from the studies is the challenge of implementing NBS within existing healthcare systems, particularly regarding logistics, personnel, and technical capacity. A multi-country study conducted in Angola, the Democratic Republic of Congo, Ghana, Liberia, Nigeria and Tanzania identified four key challenges: governance, technical, cultural, and financial, that affect the feasibility of NBS programs [5]. Notably, the study stressed that overstretched staff and weak operational processes often limit consistent delivery. Financial limitations emerged as a cross-cutting barrier. Dependence on external funding was seen to undermine local financial investment and sustainability [5]. A general shortage of essential equipment and maintenance challenges also emerged as key financial barriers [18,20].
Another study demonstrated that while screening technologies can be efficiently applied, their success was hampered by poor time management, lack of trained personnel, and poorly defined protocols [15]. This was also the case in Nigeria where follow-up inefficiencies were noted [18], and in Cameroon were uneven distribution of equipment and professionals was a key challenge [20].
Several cultural barriers have also been identified as significant challenges to the successful implementation of NBS programs across Africa. In Angola, Democratic Republic of Congo, Ghana, Liberia, Nigeria and Tanzania there was considerable variability in knowledge and perceptions of NBS among community-based staff and families [5]. Similarly, in Nigeria, some pregnant women had poor understanding of SCD and NBS, which improved only after targeted education. Another study highlighted poor communication between policymakers and user groups, which exacerbated mistrust and reinforced stigma associated with genetic disorders [21]. In the context of hearing screening, a Cameroonian study observed that negative social attitudes toward disability and hearing loss reduced the perceived importance of early testing [20].
The reviewed studies identified significant policy and governance challenges that hinder large-scale implementation and sustainability of NBS. Notable examples include weaknesses in governance structures [5] and the absence of strong national policies [16]. A Nigerian study revealed poor communication gaps between policymakers and community stakeholders [21], which impeded coordination. A South African study blamed weak policy prioritisation and lack of regulatory enforcement [19].
Urgent action is required to strengthen NBS implementation: the studies call for swift and coordinated action to transition NBS programs from fragmented pilot initiatives to fully national coverage. First, there is an urgent need for policy integration and government ownership. There is a call to fully incorporate NBS programs into national health systems to ensure accessibility, affordability, and continuity of care, rather than remaining dependent on short-term donor projects [16]. Other studies emphasise stronger governance frameworks and domestic financing to reduce reliance on external support. Development of national policies, regulatory guidelines, and standardised protocols is also encouraged [5,19]. Investment in capacity building, community education, and infrastructure strengthening was also highlighted as critical to enhance program effectiveness and acceptance [17]. Lastly, training and equitable distribution of skilled personnel and equipment to overcome operational bottlenecks was seen as an important solution [15,20].
This study mapped available literature on the status of NBS programs in Africa. Despite the existing need for NBS, the findings of this scoping review revealed a poor uptake across the continent. Several key challenges, including governance, technical, cultural, and financial factors, hampered NBS programs. The reviewed studies emphasise the need for prompt and coordinated action.
This study revealed the absence of effective NBS programs in most African countries. This is despite the urgent need for screening newborns in the region and calls by WHO and health experts to adopt nationwide NBS initiatives [1,6,10]. The absence of effective NBS programs in Africa is attributed to several challenges, including competing health priorities [5]. In contrast, several studies have demonstrated that NBS coverage is high in developed countries, such as in Europe, and is effective in reducing infant mortality [22-24].
The advancements of NBS programs in developing countries continue to face significant hurdles such as limited healthcare infrastructure, inadequate funding, lack of trained personnel, and weak policy implementation frameworks. Similarly, a study conducted in Asia Pacific noted that there are more developing programs than developed programs within the region due to challenges such as lack of funding, logistical and infrastructural issues, lack of technical expertise, and delayed government support [25]. However, the situation in many African nations is compounded by high burdens of infectious diseases such as HIV and other competing health priorities [26].
Despite these challenges, international collaborations and government involvement are seen as key to scaling up NBS programs. Efforts to empower African countries to build sustainable NBS infrastructures, such as those seen in Uganda and Nigeria, show promise. In Nigeria, for instance, pilot projects for SCD screening have improved awareness and early intervention [27]. Similarly, studies assessing HIV-1 point-of-care testing at birth demonstrate the importance of evaluating rapid testing within maternity settings to strengthen early diagnosis, though expanding such programs nationwide requires greater governmental commitment and long-term funding [28].
Strengths and limitations of this scoping review: this scoping review contributes to the body of literature on the implementation of NBS programs in developing countries, particularly in Africa. The review was guided by PRISMA-ScR, which is an international standard for the organisation and reporting of scoping reviews. This strengthened the methodology of the study, ensuring transparency and reproducibility. In addition, the inclusion of multiple reviewers in article selection minimised bias. However, some limitations exist. This review only included studies published between 2010 and 2024, potentially excluding relevant earlier literature. The exclusion of non-English publications may also have limited the comprehensiveness of the data.
Recommendations for further research: further research is recommended that includes articles published outside the 14 years covered in this review. Extending the search period beyond 2010 may capture a broader range of studies, including historical perspectives that may inform current practices. In addition, future studies should focus on country-specific assessments of NBS implementation to identify unique barriers, facilitators, and policy gaps across different health systems in Africa. Research evaluating the cost-effectiveness and feasibility of introducing or scaling up NBS programs in low-resource settings would also provide valuable evidence for policymakers.
This scoping review revealed that while NBS programs help reduce infant morbidity and mortality in Africa, their implementation remains limited and fragmented. The review identified recurring challenges related to governance, financing, technical capacity, and cultural acceptance. Despite these barriers, there are promising examples of progress in countries such as Ghana, Nigeria, and South Africa, where pilot programs have demonstrated feasibility and impact. To achieve widespread success, African countries should prioritise the integration of NBS into routine healthcare services through strong policy support, local funding, workforce training, and community education. Collaborative efforts involving governments, global health organisations, and research institutions are key to developing sustainability. Ultimately, strengthening NBS programs in Africa will improve child health and promote health equity.
What is known about this topic
- NBS is a routine, public health intervention in high-income countries that reduces preventable infant morbidity and mortality;
- SSA carries a high burden of screenable conditions for neonates, particularly SCD and congenital infections;
- Across Africa, existing NBS programs are fragmented, small-scale, pilot-based, or hospital-driven rather than integrated into national health policies.
What this study adds
- Provides a comprehensive scoping review mapping the current status, screening methodologies, and geographical distribution of NBS programs in African;
- Synthesises barriers to implementation in low-resource countries, categorising into governance weaknesses, financial constraints, technical challenges, and community-level cultural barriers;
- Highlights key facilitators such as international partnerships, targeted community health education, and government engagement, for sustainable nationwide NBS programs.
The authors declare no competing interests.
Conception, manuscript drafting, study design, data analysis and data interpretation: Stanford Chigaro. Database search: Stanford Chigaro, Maria Mvere and Takudzwa Marembo. Data collection: Stanford Chigaro, Maria Mvere and Takudzwa Marembo. Manuscript revision: Rabelani Kaela, Takudzwa Marembo and Solomon Mukwenha. All the authors read and approved the final version of this manuscript.
Table 1: characteristics of included studies
Table 1.1: characteristics of included studies
Table 1.2: characteristics of included studies
Table 1.3: characteristics of included studies
Table 1.4: characteristics of included studies
Figure 1: flow diagram of screening results
- Therrell BL, Padilla CD, Borrajo GJC, Khneisser I, Schielen PCJI, Knight-Madden J et al. Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020-2023). Int J Neonatal Screen. 2024 May 23;10(2):38. PubMed | Google Scholar
- Wojcik MH, Gold NB. Implications of Genomic Newborn Screening for Infant Mortality. Int J Neonatal Screen. 2023 Feb 28;9(1):1. PubMed | Google Scholar
- Soomann M, Prader S, Pinto Monteiro A, Zeilhofer U, Hauri-Hohl M, Güngör T et al. Reducing Mortality and Morbidity in Children with Severe Combined Immunodeficiency in Switzerland: the Role of Newborn Screening. J Clin Immunol. 2024 Jan;44(1):39. PubMed | Google Scholar
- Brunelli L, Sohn H, Brower A. Newborn sequencing is only part of the solution for better child health. Lancet Reg Health Am. 2023 Aug 26;25:100581. PubMed | Google Scholar
- Archer NM, Inusa B, Makani J, Nkya S, Tshilolo L, Tubman VN et al. Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries. BMJ Open. 2022 Mar;12(3):e057623. PubMed | Google Scholar
- Kuznik A, Habib AG, Munube D, Lamorde M. Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis. BMC Health Serv Res. 2016 Dec;16(1):304. PubMed | Google Scholar
- Green NS, Zapfel A, Nnodu OE, Franklin P, Tubman VN, Chirande L et al. The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodology. Blood Adv. 2022 Dec 27;6(24):6187-9. PubMed | Google Scholar
- Malherbe HL, Bonham J, Carrihill M, Chetty K, Conradie EH, Dercksen M et al. Newborn screening in South Africa: the past, present, and plans for the future. Rare Disease and Orphan Drugs Journal. 2024;3:7. PubMed | Google Scholar
- Ghosh P, Chowdhury R, Rahat MdA, Hossain F, Arpha NE, Kristan M et al. Dried Blood Spots (DBS): A suitable alternative to using whole blood samples for diagnostic testing of visceral leishmaniasis in the post-elimination era. Bourret TJ, editor. PLoS Negl Trop Dis. 2023 Oct 20;17(10):e0011680. PubMed | Google Scholar
- WHO Regional Office for Europe. Screening programmes: a short guide. Increase effectiveness, maximize benefits and minimize harm. Copenhagen: WHO Regional Office for Europe; 2020. Licence: CC BY-NC-SA 3.0 IGO. Accessed 4th December 2025.
- Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005 Feb;8(1):19-32. Google Scholar
- Hong QN, Fàbregues S, Bartlett G, Boardman F, Cargo M, Dagenais P et al. The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers. Educ Inf. 2018 Dec 18;34(4):285-91. Google Scholar
- Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018 Oct 2;169(7):467-73. PubMed | Google Scholar
- Bezuidenhout JK, Khoza-Shangase K, De Maayer T, Strehlau R. Outcomes of newborn hearing screening at an academic secondary level hospital in Johannesburg, South Africa. S Afr J Commun Disord. 2021 Jan 27;68(1):e1-e8. PubMed | Google Scholar
- Kanji A, Khoza-Shangase K. Feasibility of newborn hearing screening in a public hospital setting in South Africa: A pilot study. S Afr J Commun Disord. 2016 Feb 16;63(1):8 pages. PubMed | Google Scholar
- Bukini D, Nkya S, McCurdy S, Mbekenga C, Manji K, Parker M et al. Perspectives on Building Sustainable Newborn Screening Programs for Sickle Cell Disease: Experience from Tanzania. Int J Neonatal Screen. 2021 Feb 26;7(1):12. PubMed | Google Scholar
- Ezenwosu OU, Olawepo JO, Lacroix-Willliamson LJ, Itanyi IU, Ogidi A, Onyeka TC et al. Health education to promote knowledge about sickle cell disease and newborn screening in pregnant women: a community-based pilot study using the healthy beginning initiative. BMC Pregnancy Childbirth. 2024 Apr 26;24(1):321. PubMed | Google Scholar
- Lasisi AO, Onakoya PA, Lasisi TJ, Akinola MD, Tongo O. Neonatal hearing screening in a rural/sub-urban community in Nigeria, sub-Saharan Africa—A preliminary report. Int J Pediatr Otorhinolaryngol. 2014 Sep;78(9):1452-5. PubMed | Google Scholar
- Meyer ME, Swanepoel de W. Newborn hearing screening in the private health care sector - a national survey. S Afr Med J. 2011 Sep 5;101(9):665-7. PubMed | Google Scholar
- Choffor-Nchinda E, Fokouo Fogha JV, Ngo Nyeki AR, Dalil AB, Meva'a Biouélé RC, Me-Meke GP. Approach and solutions to congenital hearing impairment in Cameroon: perspective of hearing professionals. Trop Med Health. 2022 Dec;50(1):36. PubMed | Google Scholar
- Inusa BPD, Anie KA, Lamont A, Dogara LG, Ojo B, Ijei I et al. Utilising the 'Getting to Outcomes®' Framework in Community Engagement for Development and Implementation of Sickle Cell Disease Newborn Screening in Kaduna State, Nigeria. Int J Neonatal Screen. 2018 Nov 16;4(4):33. PubMed | Google Scholar
- Kalkman S, Wevers RA, Wijburg FA, Leeflang MMG. A framework for evaluating long-term impact of newborn screening. Eur J Hum Genet. 2024 Feb;32(2):146-9. PubMed | Google Scholar
- Castiñeras DE, Couce ML, Marín JL, González-Lamuño D, Rocha H. Newborn screening for metabolic disorders in Spain and worldwide. An Pedíatr (Engl Ed). 2019 Aug;91(2):128.e1-128.e14. Spanish. PubMed | Google Scholar
- Png ME, Yang M, Taylor-Phillips S, Ratushnyak S, Roberts N, White A et al. Benefits and harms adopted by health economic assessments evaluating antenatal and newborn screening programmes in OECD countries: A systematic review of 336 articles and reports. Soc Sci Med. 2022 Dec;314:115428. PubMed | Google Scholar
- Padilla CD, Therrell BL, Working Group of the Asia Pacific Society for Human Genetics on Consolidating Newborn Screening Efforts in the Asia Pacific Region. Consolidating newborn screening efforts in the Asia Pacific region: Networking and shared education. J Community Genet. 2012 Jan;3(1):35-45. PubMed | Google Scholar
- Oleribe OO, Momoh J, Uzochukwu BS, Mbofana F, Adebiyi A, Barbera T et al. Identifying Key Challenges Facing Healthcare Systems In Africa And Potential Solutions. Int J Gen Med. 2019 Nov 6;12:395-403. PubMed | Google Scholar
- Musuka HW, Iradukunda PG, Mano O, Saramba E, Gashema P, Moyo E et al. Evolving Landscape of Sickle Cell Anemia Management in Africa: A Critical Review. Trop Med Infect Dis. 2024 Nov 29;9(12):292. PubMed | Google Scholar
- Technau KG, Kuhn L, Coovadia A, Murnane PM, Sherman G. Xpert HIV-1 point-of-care test for neonatal diagnosis of HIV in the birth testing programme of a maternity hospital: a field evaluation study. Lancet HIV. 2017 Oct;4(10):e442-e448. PubMed | Google Scholar





